| # | Drug | Count |
|---|---|---|
| 0 | LAMIVUDINE AND ZIDOVUDINE | 18 |
| 1 | NEVIRAPINE | 18 |
| 2 | LOPINAVIR AND RITONAVIR | 17 |
| 3 | EFAVIRENZ | 15 |
| 4 | EMTRICITABINE | 6 |
| 5 | ARIPIPRAZOLE | 3 |
| 6 | ESCITALOPRAM | 3 |
| 7 | LAMOTRIGINE | 3 |
| 8 | LEVETIRACETAM | 3 |
| 9 | OMEPRAZOLE MAGNESIUM | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LAMIVUDINE AND ZIDOVUDINE | 18 | 0.0023 |
| 1 | NEVIRAPINE | 18 | 0.0020 |
| 2 | EFAVIRENZ | 15 | 0.0014 |
| 3 | LOPINAVIR AND RITONAVIR | 17 | 0.0013 |
| 4 | FLUCYTOSINE | 1 | 0.0007 |
| 5 | FOSPHENYTOIN SODIUM | 1 | 0.0004 |
| 6 | CAPSAICIN | 1 | 0.0003 |
| 7 | DOPAMINE HYDROCHLORIDE | 1 | 0.0003 |
| 8 | SOLRIAMFETOL | 1 | 0.0003 |
| 9 | NALOXEGOL OXALATE | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 18 | 0.0007 |
| 1 | Nucleoside Analog Antifungal [EPC] | 1 | 0.0007 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 19 | 0.0004 |
| 3 | Protease Inhibitor [EPC] | 17 | 0.0004 |
| 4 | Cytochrome P450 3A Inhibitor [EPC] | 17 | 0.0003 |
| 5 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 6 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 1 | 0.0002 |
| 7 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 20 | 0.0002 |
| 8 | Sigma-1 Agonist [EPC] | 1 | 0.0001 |
| 9 | Chloride Channel Activator [EPC] | 1 | 0.0001 |